Corporate Leadership

Our Executive Committee

Corporate Leadership

Our Executive Committee

Corporate Leadership

Our Executive Committee

Olivier Schiller

Olivier Schiller
Chief Executive Officer (CEO)

After studying engineering at Ecole Centrale de Lille, Olivier Schiller enlisted in the French Navy where he became Reserve Officer on board a nuclear submarine. Then, he joined the advisory department of the firm Arthur Andersen.

After completing an MBA at HEC Paris, he became Septodont Chief Financial Officer in 1993. In 2001, Olivier Schiller was made General Manager. He became President and CEO of the group in 2012.

Olivier Schiller is a member of the Val de Marne Chamber of Commerce, an advisor to the Bank of France, an advisor to the NYU dental university and is on board of the exhibition committee of the French Dental Association and of the French Israeli Chamber of Commerce.

Olivier Schiller

After studying engineering at Ecole Centrale de Lille, Olivier Schiller enlisted in the French Navy where he became Reserve Officer on board a nuclear submarine. Then, he joined the advisory department of the firm Arthur Andersen.

After completing an MBA at HEC Paris, he became Septodont Chief Financial Officer in 1993. In 2001, Olivier Schiller was made General Manager. He became President and CEO of the group in 2012.

Olivier Schiller is a member of the Val de Marne Chamber of Commerce, an advisor to the Bank of France, an advisor to the NYU dental university and is on board of the exhibition committee of the French Dental Association and of the French Israeli Chamber of Commerce.

Todd Beechey

Todd Beechey
Chief Financial Officer (CFO)

Todd joined Septodont in 2007 as the Vice President of Finance in North America, responsible for managing all aspects of the financial management of the North American operations of Septodont, and additionally managing the IT department. In 2013, Todd was given the additional responsibilities of Corporate Business Development, and then in 2014, a new role as the President of Novocol Healthcare was also established. In November 2015, Todd was appointed the Chief Financial Officer for the Septodont Group.

Prior to joining Septodont, Todd worked in a variety of industries, including computer software, aerospace manufacturing and industrial automation equipment.

Todd is a CPA/CMA (designation received in 1995) and in 2013 received his MBA from the University of Toronto – Rotman School of Management, as well as an EMBA from the University of St. Gallen in Switzerland.

Todd Beechey

Todd joined Septodont in 2007 as the Vice President of Finance in North America, responsible for managing all aspects of the financial management of the North American operations of Septodont, and additionally managing the IT department.  In 2013, Todd was given the additional responsibilities of Corporate Business Development, and then in 2014, a new role as the President of Novocol Healthcare was also established. In November 2015, Todd was appointed the Chief Financial Officer for the Septodont Group.

Prior to joining Septodont, Todd worked in a variety of industries, including computer software, aerospace manufacturing and industrial automation equipment.

Todd is a CPA/CMA (designation received in 1995) and in 2013 received his MBA from the University of Toronto – Rotman School of Management, as well as an EMBA from the University of St. Gallen in Switzerland.

Knet Chiu

Kent Chiu
Chief Operating Officer (COO)

Kent received his CEGEP Diploma in Science from McGill University, and his Bachelor of Pharmacy degree from the University of British Columbia.

With 39 years’ experience in the pharmaceutical industry, Kent has worked for companies such as Novopharm and Apotex in various capacities.

Kent is currently the Chief Operating Officer of Septodont responsible for plant operations. In addition, Kent is responsible for North America, Asia Pacific, and India’s P&L. Kent is also overseeing the expansion of the Medical division.

In his spare time, Kent loves to catch up with current affairs, golfing and skiing.

Kent Chiu

Kent received his CEGEP Diploma in Science from McGill University, and his Bachelor of Pharmacy degree from the University of British Columbia.

With 39 years’ experience in the pharmaceutical industry, Kent has worked for companies such as Novopharm and Apotex in various capacities.

Kent is currently the Chief Operating Officer of Septodont responsible for plant operations. In addition, Kent is responsible for North America, Asia Pacific, and India’s P&L. Kent is also overseeing the expansion of the Medical division.

In his spare time, Kent loves to catch up with current affairs, golfing and skiing.

Sophie Ragot-Satgé

Sophie Ragot-Satgé
President EMEA / Chief Marketing Officer (CMO)

Sophie Ragot-Satgé joined Septodont in 2007 to create and lead its global marketing organization. In October 2012, Sophie was given, in addition, the P&L responsibility for Europe Middle-East Africa. She was named Chief Marketing Officer for the group & Senior VP Sales for EMEA.

In November 2015, Sophie was appointed President EMEA, while keeping her global marketing responsibilities, as Chief Marketing Officer.

She is also Chairman of Septodont’s EMEA Executive committee and serves as a member of the Corporate Executive Committee.

Sophie began her career in 1987, at Brosse USA Inc., the US subsidiary of a packaging glass manufacturer for the fragrance industry. In 1993, she joined Johnson & Johnson, where she held, over the next 13 years, various management positions within the Vision Care group, including Marketing Director France, Country Manager Benelux, and Marketing Director EMEA.

Sophie is a graduate from the French business school ISC Paris. She holds an MBA from INSEAD (1993).

Sophie Ragot-Satgé

Sophie Ragot-Satgé joined Septodont in 2007 to create and lead its global marketing organization. In October 2012, Sophie was given, in addition, the P&L responsibility for Europe Middle-East Africa. She was named Chief Marketing Officer for the group & Senior VP Sales for EMEA.

In November 2015, Sophie was appointed President EMEA, while keeping her global marketing responsibilities, as Chief Marketing Officer.

She is also Chairman of Septodont’s EMEA Executive committee and serves as a member of the Corporate Executive Committee.

Sophie began her career in 1987, at Brosse USA Inc., the US subsidiary of a packaging glass manufacturer for the fragrance industry. In 1993, she joined Johnson & Johnson, where she held, over the next 13 years, various management positions within the Vision Care group, including Marketing Director France, Country Manager Benelux, and Marketing Director EMEA.

Sophie is a graduate from the French business school ISC Paris. She holds an MBA from INSEAD (1993).

Paul Mondock

Paul Mondock
President, Americas

A 28 year veteran of Septodont, Paul has held numerous roles with increasing responsibility. He currently serves as President for the Americas, with P&L responsibilities for North, South, and Central America. He is also Chairman of Septodont’s North American Executive Committee and serves as a member of the corporate Executive Management Committee.

In addition to his company responsibilities Paul is also involved at the Board level with multiple industry related non-profit organizations.

Paul received his BS in Business Management from the University of Pittsburgh and his MBA from Temple University’s Fox School of Business.

Paul Mondock

A 28 year veteran of Septodont, Paul has held numerous roles with increasing responsibility. He currently serves as President for the Americas, with P&L responsibilities for North, South, and Central America. He is also Chairman of Septodont’s North American Executive Committee and serves as a member of the corporate Executive Management Committee.

In addition to his company responsibilities Paul is also involved at the Board level with multiple industry related non-profit organizations.

Paul received his BS in Business Management from the University of Pittsburgh and his MBA from Temple University’s Fox School of Business.

Laurent Artaud

Laurent Artaud
Chief Quality, Regulatory & Medical Officer

Laurent Artaud, doctor of pharmacy and holder of master’s degrees in quality assurance and pharmaceutical sciences, began his career as a Quality Assurance Manager at Rhône-Poulenc-Rorer (now Sanofi) in France and the United States and then became General Manager and Qualified Person at Ethymed, subsidiary of the Ethypharm group, specialised in transdermal systems.

In October 2000, Laurent joined Septodont and held a series of positions as Site Quality Director until 2001, as Quality Director for Europe until 2006 and, finally, as Compliance Director supervising the activities of the Septodont Group relating to Quality Assurance and Regulatory Affairs until December 2007. During this period, Laurent contributed significantly to the structuring of the Septodont group in the area of Compliance.

From 2007 to 2014, Laurent worked as Vice President of Quality and Qualified Person at Stallergenes, where he contributed to the registration and launch of a immunotherapy tablet treatment in around 30 countries throughout the world, including the United States and Japan. In October 2014, Laurent returned to the Septodont Group as Chief Scientific Officer, where he manages activities relating to Research and Development, Medical Affairs and Regulatory Affairs.

Laurent Artaud

Laurent Artaud, doctor of pharmacy and holder of master’s degrees in quality assurance and pharmaceutical sciences, began his career as a Quality Assurance Manager at Rhône-Poulenc-Rorer (now Sanofi) in France and the United States and then became General Manager and Qualified Person at Ethymed, subsidiary of the Ethypharm group, specialised in transdermal systems.

In October 2000, Laurent joined Septodont and held a series of positions as Site Quality Director until 2001, as Quality Director for Europe until 2006 and, finally, as Compliance Director supervising the activities of the Septodont Group relating to Quality Assurance and Regulatory Affairs until December 2007. During this period, Laurent contributed significantly to the structuring of the Septodont group in the area of Compliance.

From 2007 to 2014, Laurent worked as Vice President of Quality and Qualified Person at Stallergenes, where he contributed to the registration and launch of a immunotherapy tablet treatment in around 30 countries throughout the world, including the United States and Japan. In October 2014, Laurent returned to the Septodont Group as Chief Scientific Officer, where he manages activities relating to Research and Development, Medical Affairs and Regulatory Affairs.

Bruce Markham

Bruce Markham
Executive Vice-President (EVP) of Operations

Bruce joined Septodont in 2010 and has more than two decades of pharmaceutical, medical device and management experience in engineering and operations.

He holds a Bachelor of Engineering in Chemical Engineering from McGill University, and a MBA from the University of Toronto’s Rotman School of Management.

Bruce  is currently managing all of our manufacturing sites globally and is also in charge of the Corporate Engineering and Supply Chain functions.

Bruce Markham

Bruce joined Septodont in 2010 and has more than two decades of pharmaceutical, medical device and management experience in engineering and operations.

He holds a Bachelor of Engineering in Chemical Engineering from McGill University, and a MBA from the University of Toronto’s Rotman School of Management.

Bruce  is currently managing all of our manufacturing sites globally and is also in charge of the Corporate Engineering and Supply Chain functions.

Picture of Atif Zia President, Novocol Healthcare / Vice-President & General Manager, Operations, Americas

Atif Zia

President, Novocol Healthcare / Vice-President & General Manager, Operations, Americas

Atif Zia joined Septodont in 2009 to lead Septodont’s Cambridge site as Vice-President and General Manager. Atif’s executive responsibilities expanded to include the Louisville site in 2013 and DLA Pharma in Brazil in 2016.

In late 2015 Atif was appointed President of Novocol Healthcare to drive the group’s diversification strategy into the pharma market through the Cambridge and Louisville manufacturing sites. Atif joined the Corporate Executive Committee in April 2018.

Prior to joining Septodont, Atif spent 14 years at Apotex, having served in a wide range of operations leadership roles. During his tenure there he made a significant impact on the company’s rapid growth in becoming a world leader in generic ophthalmics, injectables, nasal sprays and oral liquids.

Atif graduated from University of Toronto with a degree in Human Biology and is currently an MBA candidate at the Rotman School of Management.

Picture of Atif Zia President, Novocol Healthcare / Vice-President & General Manager, Operations, Americas

Atif Zia joined Septodont in 2009 to lead Septodont’s Cambridge site as Vice-President and General Manager. Atif’s executive responsibilities expanded to include the Louisville site in 2013 and DLA Pharma in Brazil in 2016.

In late 2015 Atif was appointed President of Novocol Healthcare to drive the group’s diversification strategy into the pharma market through the Cambridge and Louisville manufacturing sites. Atif joined the Corporate Executive Committee in April 2018.

Prior to joining Septodont, Atif spent 14 years at Apotex, having served in a wide range of operations leadership roles. During his tenure there he made a significant impact on the company’s rapid growth in becoming a world leader in generic ophthalmics, injectables, nasal sprays and oral liquids.

Atif graduated from University of Toronto with a degree in Human Biology and is currently an MBA candidate at the Rotman School of Management.

Aïcha Goudiaby

Chief HR & Communications Officer

Aïcha is Septodont’s Chief Human Resources & Communications Officer. She joined the company in 2016 with the mandate to tell the Septodont story in new and compelling ways. She leads the team responsible for employee communications and media relations. Over the years, she increased her scope of responsibility and started to work closely with the group’s human resources teams in all areas of HR. Most recently, she served as Director of HR Development and Corporate Communications.

Aïcha started her career at GE Healthcare where she held internal communications and public relations leadership roles. She then joined Philips Lighting where she helped drive the merger communication strategy and post-merger integration process of the Automotive and LED businesses, based out of California.

Aïcha is a graduate of CELSA – “Ecole des Hautes Etudes en Sciences de l’Information et de la Communication”. She also holds an Executive Master in Marketing & Communications from ESCP Europe and an Executive Master in Business Administration from ESSEC Business School.

Aïcha Goudiaby

Aïcha is Septodont’s Chief Human Resources & Communications Officer. She joined the company in 2016 with the mandate to tell the Septodont story in new and compelling ways. She leads the team responsible for employee communications and media relations. Over the years, she increased her scope of responsibility and started to work closely with the group’s human resources teams in all areas of HR. Most recently, she served as Director of HR Development and Corporate Communications.

Aïcha started her career at GE Healthcare where she held internal communications and public relations leadership roles. She then joined Philips Lighting where she helped drive the merger communication strategy and post-merger integration process of the Automotive and LED businesses, based out of California.

Aïcha is a graduate of CELSA – “Ecole des Hautes Etudes en Sciences de l’Information et de la Communication”. She also holds an Executive Master in Marketing & Communications from ESCP Europe and an Executive Master in Business Administration from ESSEC Business School.